Nuvectis Pharma NVCT
$19.39 −$0.45 (-2.27%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $19.39 0.00%
Open$19.60
Prev close$19.84
Day range$19.02 – $20.18
Volume301.6K
Market cap$666.80M
P/E (TTM)–
Dividend yield–
NVCT Stock News
Headlines matching Nuvectis Pharma or the NVCT ticker, most recent first.
- Maxim Group Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Maintains Target Price $30
- H.C. Wainwright Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Maintains Target Price $39
- Lucid Capital Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Raises Target Price to $34 Positive
- Cantor Fitzgerald Initiates Nuvectis Pharma(NVCT.US) With Buy Rating
- Roth MKM Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Maintains Target Price $33
- Roth MKM Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Raises Target Price to $33 Positive
- Maxim Group Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Raises Target Price to $30 Positive
- Lucid Capital Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Raises Target Price to $22 Positive
- H.C. Wainwright Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Raises Target Price to $39 Positive
- H.C. Wainwright Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Maintains Target Price $13
- H.C. Wainwright Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Raises Target Price to $13 Positive
- Maxim Group Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Maintains Target Price $17
- H.C. Wainwright Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Maintains Target Price $10
- Analysts Offer Insights on Healthcare Companies: Nuvectis Pharma (NVCT), Tenet Healthcare (THC) and Upstream Bio, Inc. (UPB)
- Maxim Group Maintains Nuvectis Pharma(NVCT.US) With Buy Rating, Maintains Target Price $30
No comments yet — be the first to weigh in on NVCT.
Sign in to join the discussion.